Active ingredient
Papaverine
4 finished FDA listings contain Papaverine as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- PAPAVERINE HYDROCHLORIDE
- Dosage forms
- Injection, Injection, Solution
- Routes
- Intramuscular, Intravenous, Parenteral
- Manufacturers / labelers
- 4
- Strengths listed
- 30 mg/ml
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 7895
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
No matching Drugs@FDA applications.
Official labeling on DailyMed
- PAPAVERINE HYDROCHLORIDE INJECTION, SOLUTION [AMERICAN REGENT, INC.] · version 9 · 2026-07-28
- PAPAVERINE HYDROCHLORIDE INJECTION, SOLUTION [BPI LABS LLC] · version 9 · 2025-12-29
- PAPAVERINE HYDROCHLORIDE INJECTION, SOLUTION [ORYZA PHARMACEUTICALS INC.] · version 4 · 2025-01-15
- PAPAVERINE HYDROCHLORIDE INJECTION [NEXUS PHARMACEUTICALS, LLC] · version 5 · 2024-12-11
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.